Robert Russell1, David F Bauer2, Susan M Goobie3,4, Thorsten Haas5, Marianne E Nellis6, Daniel K Nishijima7, Adam M Vogel8, Jacques Lacroix9. 1. Pediatric General Surgery, Children's of Alabama, Birmingham, AL. 2. Pediatric Neurosurgery, Baylor College of Medicine, Texas Children's Hospital, Houston, TX. 3. Harvard Medical School, Boston, MA. 4. Department of Anesthesiology, Critical Care & Pain Medicine, Boston Children's Hospital, Boston, MA. 5. Department of Pediatric Anesthesia, Zurich University Children's Hospital, Zurich, Switzerland. 6. Division of Pediatric Critical Care Medicine, Weill Cornell Medicine, New York, NY. 7. Department of Emergency Medicine, CTSC Clinical Research Center and Trial Innovation Network, University of California Davis School of Medicine, Sacramento, CA. 8. Surgery and Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX. 9. Division of Pediatric Critical Care, Department of Pediatrics, Sainte-Justine Hospital, Université de Montréal, Montreal, QC, Canada.
Abstract
OBJECTIVES: To present consensus statements and supporting literature for plasma and platelet transfusions in critically ill children with severe trauma, traumatic brain injury, and/or intracranial hemorrhage from the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding. DESIGN: Systematic review and consensus conference of international, multidisciplinary experts in platelet and plasma transfusion management of critically ill children. SETTING: Not applicable. PATIENTS: Critically ill neonates and children with severe trauma, traumatic brain injury, and/or intracranial hemorrhage. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A panel of eight experts developed expert-based statements for plasma and platelet transfusions in critically ill neonates and children with severe trauma, traumatic brain injury, and/or intracranial hemorrhage. These statements were reviewed and ratified by the 29 Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding experts. A systematic review was conducted using MEDLINE, EMBASE, and Cochrane Library databases, from inception to December 2020. Consensus was obtained using the Research and Development/University of California, Los Angeles Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method. We developed one good practice statement and six expert consensus statements. CONCLUSIONS: The lack of evidence precludes proposing recommendations on monitoring of the coagulation system and on plasma and platelets transfusion in critically ill pediatric patients with severe trauma, severe traumatic brain injury, or nontraumatic intracranial hemorrhage.
OBJECTIVES: To present consensus statements and supporting literature for plasma and platelet transfusions in critically ill children with severe trauma, traumatic brain injury, and/or intracranial hemorrhage from the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding. DESIGN: Systematic review and consensus conference of international, multidisciplinary experts in platelet and plasma transfusion management of critically ill children. SETTING: Not applicable. PATIENTS: Critically ill neonates and children with severe trauma, traumatic brain injury, and/or intracranial hemorrhage. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A panel of eight experts developed expert-based statements for plasma and platelet transfusions in critically ill neonates and children with severe trauma, traumatic brain injury, and/or intracranial hemorrhage. These statements were reviewed and ratified by the 29 Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding experts. A systematic review was conducted using MEDLINE, EMBASE, and Cochrane Library databases, from inception to December 2020. Consensus was obtained using the Research and Development/University of California, Los Angeles Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method. We developed one good practice statement and six expert consensus statements. CONCLUSIONS: The lack of evidence precludes proposing recommendations on monitoring of the coagulation system and on plasma and platelets transfusion in critically ill pediatric patients with severe trauma, severe traumatic brain injury, or nontraumatic intracranial hemorrhage.
Authors: Mary J Edwards; Michael B Lustik; Margaret E Clark; Kevin M Creamer; David Tuggle Journal: J Trauma Acute Care Surg Date: 2015-02 Impact factor: 3.313
Authors: Jeanne E Hendrickson; Beth H Shaz; Greg Pereira; Elizabeth Atkins; Karen K Johnson; Gaobin Bao; Kirk A Easley; Cassandra D Josephson Journal: J Pediatr Date: 2011-09-16 Impact factor: 4.406
Authors: Jeanne E Hendrickson; Beth H Shaz; Greg Pereira; Paul M Parker; Paula Jessup; Falisha Atwell; Beth Polstra; Elizabeth Atkins; Karen K Johnson; Gaobin Bao; Kirk A Easley; Cassandra D Josephson Journal: Transfusion Date: 2011-12-01 Impact factor: 3.157
Authors: Christine M Leeper; Matthew D Neal; Timothy R Billiar; Jason L Sperry; Barbara A Gaines Journal: J Trauma Acute Care Surg Date: 2018-07 Impact factor: 3.313
Authors: Susan E Rowell; Ronald R Barbosa; Tori C Lennox; Kelly A Fair; Abigail J Rao; Samantha J Underwood; Martin A Schreiber Journal: J Trauma Acute Care Surg Date: 2014-12 Impact factor: 3.313
Authors: Oliver Karam; Robert T Russell; Paul Stricker; Adam M Vogel; Scot T Bateman; Stacey L Valentine; Philip C Spinella Journal: Pediatr Crit Care Med Date: 2018-09 Impact factor: 3.624
Authors: Marianne E Nellis; Oliver Karam; Stacey L Valentine; Scot T Bateman; Kenneth E Remy; Jacques Lacroix; Jill M Cholette; Melania M Bembea; Robert T Russell; Marie E Steiner; Susan M Goobie; Marisa Tucci; Paul A Stricker; Simon J Stanworth; Meghan Delaney; Lani Lieberman; Jennifer A Muszynski; David F Bauer; Katherine Steffen; Daniel Nishijima; Juan Ibla; Sitaram Emani; Adam M Vogel; Thorsten Haas; Ruchika Goel; Gemma Crighton; Diana Delgado; Michelle Demetres; Robert I Parker Journal: Pediatr Crit Care Med Date: 2022-01-01 Impact factor: 3.624